LeadTop Pharmaceutical Machinery Co., LTD

                Your Best Pharmaceutical Production Solution!

Home
Products
About Us
Factory Tour
Quality Control
Contact Us
Request A Quote
Home News

Company News

Good quality Automatic Labeling Machine for sales
Good quality Automatic Labeling Machine for sales
The Fluid Bed Dryer is really strong machine, bro!

—— Bob, California, USA

We are so glad to know you and be your partner. Welcome to Philippines

—— Edgar, Davao, Philippines

Conductivity of Purified Water after your double RO machine is 0.54 since our raw water is 428. Thanks, my friend.

—— Habibur, Dhaka, Bangladesh

su empresa es un genio de maquinaria! Glad to be your partner in Peru.

—— Diaz, Lima, Peru

I'm Online Chat Now
Company News
china latest news about AstraZeneca's Bydureon gets a facelift, but can it stand out in a GLP-1 market that's only getting tougher?

AstraZeneca's Bydureon gets a facelift, but can it stand out in a GLP-1 market that's only getting tougher?

[2017-10-25 16:46:56]
AstraZeneca’s Bydureon took a blow back in May when it failed to cut down cardiovascular risks in Type 2 diabetes patients. But the company is hoping a new formulation will give the medication some competitive firepower. The British drugmaker has scored an approval for Bydureon BCise, which has ... Read More
china latest news about Novartis edges Roche in targeted melanoma with Tafinlar-Mekinist adjuvant 'breakthrough'

Novartis edges Roche in targeted melanoma with Tafinlar-Mekinist adjuvant 'breakthrough'

[2017-10-25 16:46:14]
Score one for Novartis in its quest to expand its cancer-fighting combo, Tafinlar and Mekinist. Monday, the FDA bestowed its “breakthrough” tag on the pair in adjuvant, BRAF V600 mutation-positive melanoma, setting it up for a quick trip down the regulatory path to approval. The agency’s decision to ... Read More
china latest news about GlaxoSmithKline picks up NICE recommendation for Strimvelis, a €594,000 gene therapy

GlaxoSmithKline picks up NICE recommendation for Strimvelis, a €594,000 gene therapy

[2017-10-25 16:44:09]
Despite being one of the most expensive drugs in the world, GlaxoSmithKline's gene therapy Strimvelis won the backing of the often stingy U.K. cost watchdogs to treat a rare disease called ADA-SCID, or "bubble boy" syndrome. The drug, which costs €594,000 (about $700,000), is a one-time treatment ... Read More
china latest news about Lilly weighs spinoff of bulked up Elanco even as it beats Street estimates in Q3

Lilly weighs spinoff of bulked up Elanco even as it beats Street estimates in Q3

[2017-10-25 16:41:55]
Already working to slim down with thousands of job cuts, Eli Lilly announced on Tuesday it's looking at options for animal health business Elanco that could include a sale. At the same time, the drugmaker reported Street-beating sales for the third quarter, prompting it to boost its guidance for the ... Read More
china latest news about Akorn sterile plant in Illinois smacked again by the FDA

Akorn sterile plant in Illinois smacked again by the FDA

[2017-10-25 16:06:55]
An Akorn sterile injectables plant in Illinois is in hot water with the FDA again, but this time it may be a problem for Fresenius Kabi, which is buying the generics manufacturer in a $4.3 billion deal. According to a recently posted FDA Form 483, the agency found new issues with Akorn’s sterile ... Read More
china latest news about Mylan blasts Allergan's 'desperate' tribal licensing deal on Restasis

Mylan blasts Allergan's 'desperate' tribal licensing deal on Restasis

[2017-09-15 15:09:04]
Mylan has had no shortage of critics over the last year as it suffered from a stinging EpiPen pricing scandal. Now, the generic giant is dishing out barbs of its own, blasting Allergan for a new licensing deal with the Saint Regis Mohawk Tribe that’s designed to shield eye drug Restasis from ... Read More
china latest news about FDA panel unanimously endorses Glaxo's Shingrix as $1B market duel nears

FDA panel unanimously endorses Glaxo's Shingrix as $1B market duel nears

[2017-09-15 15:08:30]
Marking a big step in its march toward potential approval, GlaxoSmithKline’s shingles vaccine Shingrix won the support of an FDA panel as experts touted its strengths over Merck’s Zostavax. The shot, slated to be a blockbuster, now heads to the FDA for an October action date. Asked whether the ... Read More
china latest news about EASD: AstraZeneca's Farxiga cuts blood sugar, weight and insulin use in Type 1 diabetes study

EASD: AstraZeneca's Farxiga cuts blood sugar, weight and insulin use in Type 1 diabetes study

[2017-09-15 15:07:57]
LISBON, Portugal—AstraZeneca’s Farxiga is already battling it out with its SGLT2 rivals in Type 2 diabetes. But it may have a future in another field, too. Thursday at the European Society for the Study of Diabetes (EASD) annual meeting, the drugmaker rolled out 24-week results from a phase 3 trial ... Read More
china latest news about California lawmakers pass drug pricing bill opposed by PhRMA, sending it to the governor

California lawmakers pass drug pricing bill opposed by PhRMA, sending it to the governor

[2017-09-15 15:07:18]
Even after a contentious drug pricing ballot initiative in California fell short last year, the issue hasn’t gone away. Now, lawmakers in the state have approved a pricing transparency bill strongly opposed by PhRMA, sending it to Gov. Jerry Brown for a decision. California’s Senate Bill 17 would ... Read More
china latest news about Amgen and Allergan win FDA nod for biosimilar of Avastin, Roche's $3B seller

Amgen and Allergan win FDA nod for biosimilar of Avastin, Roche's $3B seller

[2017-09-15 15:04:50]
The FDA has ushered in a new era in lower cost cancer medicines with its approval of Amgen’s and Allergan's Mvasi, a biosimilar of Roche’s blockbuster drug Avastin. The agency Thursday gave the biosimilar approval in each of Avastin’s approved indications, which include treating colorectal, lung, ... Read More
Page 1 of 5|< 1 2 3 4 5 >|